Table 1 Baseline characteristics of involved CAD patients and controls
Characteristics | CAD (n = 100) | Control (n = 100) | P |
|---|---|---|---|
Age, years | 64.1 ± 10.9 | 63.1 ± 8.2 | 0.452 |
Male, n (%) | 66 (66) | 54 (54) | 0.112 |
EH, n (%) | 66 (66) | 61 (61) | 0.557 |
DM, n (%) | 26 (26) | 16 (16) | 0.118 |
Smoking, n (%) | 44 (44) | 32 (32) | 0.109 |
TC, mmol/l | 4.70 ± 1.16 | 4.44 ± 0.81 | 0.064 |
TG, mmol/l | 1.57 (1.06–2.40) | 1.37 (0.96–2.11) | 0.118 |
HDL-C, mmol/l | 1.06 ± 0.23 | 1.20 ± 0.33 | < 0.001 |
LDL-C, mmol/l | 3.04 ± 0.98 | 2.71 ± 0.75 | 0.009 |
ApoAI, g/l | 1.17 ± 0.20 | 1.31 ± 0.25 | < 0.001 |
ApoB, g/l | 1.00 ± 0.32 | 0.94 ± 0.22 | 0.081 |